MarketPeel
Insider Trading Intelligence
PM

Pharis Mohideen

DBVT
CHIEF MEDICAL OFFICER · DBV TECHNOLOGIES S.A. · CIK 0001760395
FILING MIX · LIFETIME44%/56%
BUYS
12
SELLS
15
TOTAL VALUE
$43.7K
COMPANIES
1
ACTIVE SINCE
Nov 2021
HOLDINGS NOW
144,995
AVG SELL PX
$2.11
TRADE KIND
SHOWING 27 / 27
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
15 backtested trades · 8 horizons · 15 pending
Forward-return performance of every backtestable P/S trade by Pharis Mohideen, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d15+46.67%+7.88%+0.37%+7.51%-0.51%
14d15+53.33%+6.65%+1.20%+5.44%-3.27%
30d15+33.33%+12.25%+1.65%+10.60%+6.25%
60d15+40.00%+22.20%+2.72%+19.48%+2.07%
90d15+46.67%+27.74%+4.12%+23.62%+2.31%
180d15(1 pending)+35.71%+76.70%+8.51%+68.19%+34.46%
1y15(4 pending)+27.27%+172.82%+17.79%+155.03%+84.44%
2y15(10 pending)+40.00%+66.42%+45.74%+20.68%+24.14%
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
DBVT · 144,995 shares · as of Jan 29, 2026
063,250126,500189,750253,00020222023202420252026SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
FLOW · 12 buys / 15 sellsCOVERAGE · 18 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
DBVT
DBV TECHNOLOGIES S.A.
SALE
Chief Medical Officer
534$4.86$2.6K144,995Jan 29, 2026Feb 2, 2026View →
DBVT
DBV TECHNOLOGIES S.A.
PURCHASEGRANT
Stock grant
44,000145,529Nov 21, 2025Nov 25, 2025View →
DBVT
DBV TECHNOLOGIES S.A.
PURCHASEGRANT
Stock grant
253,000253,000Nov 21, 2025Nov 25, 2025View →
DBVT
DBV TECHNOLOGIES S.A.
SALE
Chief Medical Officer
1,624$2.77$4.5K101,529Nov 21, 2025Nov 25, 2025View →
DBVT
DBV TECHNOLOGIES S.A.
SALE
Chief Medical Officer
6,496$2.88$18.7K103,153Nov 20, 2025Nov 25, 2025View →
DBVT
DBV TECHNOLOGIES S.A.
SALE
Chief Medical Officer
464$2.22$1.0K109,649Jul 29, 2025Jul 31, 2025View →
DBVT
DBV TECHNOLOGIES S.A.
SALE
Chief Medical Officer
397$1.84$730110,113May 22, 2025May 27, 2025View →
DBVT
DBV TECHNOLOGIES S.A.
SALE
Chief Medical Officer
600$0.85$510110,510Jan 30, 2025Jan 31, 2025View →
DBVT
DBV TECHNOLOGIES S.A.
SALE
Chief Medical Officer
565$0.57$322111,110Nov 25, 2024Nov 27, 2024View →
DBVT
DBV TECHNOLOGIES S.A.
SALE
Chief Medical Officer
342$0.53$181111,675Nov 22, 2024Nov 27, 2024View →
DBVT
DBV TECHNOLOGIES S.A.
PURCHASEGRANT
Stock grant
35,000114,367Nov 21, 2024Nov 25, 2024View →
DBVT
DBV TECHNOLOGIES S.A.
SALE
Chief Medical Officer
2,350$0.54$1.3K112,017Nov 21, 2024Nov 25, 2024View →
DBVT
DBV TECHNOLOGIES S.A.
PURCHASEGRANT
Stock grant
215,000215,000Nov 21, 2024Nov 25, 2024View →
DBVT
DBV TECHNOLOGIES S.A.
SALE
Chief Medical Officer
1,785$0.98$1.7K79,367Jul 29, 2024Jul 31, 2024View →
DBVT
DBV TECHNOLOGIES S.A.
SALE
Chief Medical Officer
660$1.36$89881,152May 24, 2024May 29, 2024View →
DBVT
DBV TECHNOLOGIES S.A.
SALE
Chief Medical Officer
382$1.38$52781,812May 22, 2024May 29, 2024View →
DBVT
DBV TECHNOLOGIES S.A.
SALE
Chief Medical Officer
2,245$1.74$3.9K82,194Nov 22, 2023Dec 19, 2023View →
DBVT
DBV TECHNOLOGIES S.A.
PURCHASEGRANT
Stock grant
35,00084,439Nov 20, 2023Nov 22, 2023View →
DBVT
DBV TECHNOLOGIES S.A.
PURCHASEGRANT
Stock grant
215,000215,000Nov 20, 2023Nov 22, 2023View →
DBVT
DBV TECHNOLOGIES S.A.
SALE
Chief Medical Officer
469$3.54$1.7K49,439May 24, 2023Aug 14, 2023View →
DBVT
DBV TECHNOLOGIES S.A.
SALE
Chief Medical Officer
1,792$2.88$5.2K49,908Nov 24, 2022Aug 14, 2023View →
DBVT
DBV TECHNOLOGIES S.A.
PURCHASEGRANT
Stock grant
115,000115,000Nov 21, 2022Aug 14, 2023View →
DBVT
DBV TECHNOLOGIES S.A.
PURCHASEGRANT
Stock grant
17,50051,700Nov 21, 2022Aug 14, 2023View →
DBVT
DBV TECHNOLOGIES S.A.
PURCHASEGRANT
Stock grant
10,00034,200Jul 29, 2022Aug 14, 2023View →
DBVT
DBV TECHNOLOGIES S.A.
PURCHASEGRANT
Stock grant
100,000100,000Jul 29, 2022Aug 14, 2023View →
DBVT
DBV TECHNOLOGIES S.A.
PURCHASEGRANT
Stock grant
8,70024,200Nov 22, 2021Nov 24, 2021View →
DBVT
DBV TECHNOLOGIES S.A.
PURCHASEGRANT
Stock grant
95,40095,400Nov 22, 2021Nov 24, 2021View →
Other insiders · DBVT
Loading peer insiders…
About this filer
CIK 0001760395
ROLE
Chief Medical Officer
PRIMARY
DBVT
COMPANIES
1
ACTIVE SINCE
Nov 2021
MARKETPEEL · /INSIDER/0001760395DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback